90 related articles for article (PubMed ID: 11259538)
21. Metformin sinusoidal efflux from the liver is consistent with negligible biliary excretion and absence of enterohepatic cycling.
Zamek-Gliszczynski MJ; Bao JQ; Day JS; Higgins JW
Drug Metab Dispos; 2013 Nov; 41(11):1967-71. PubMed ID: 24009308
[TBL] [Abstract][Full Text] [Related]
22. Effect of phenobarbital and p-hydroxyphenobarbital glucuronide on acetaminophen metabolites in isolated rat hepatocytes: use of a kinetic model to examine the rates of formation and egress.
Studenberg SD; Brouwer KL
J Pharmacokinet Biopharm; 1993 Apr; 21(2):175-94. PubMed ID: 8229679
[TBL] [Abstract][Full Text] [Related]
23. Hepatic disposition of the acyl glucuronide 1-O-gemfibrozil-beta-D-glucuronide: effects of clofibric acid, acetaminophen, and acetaminophen glucuronide.
Sabordo L; Sallustio BC; Evans AM; Nation RL
J Pharmacol Exp Ther; 2000 Oct; 295(1):44-50. PubMed ID: 10991959
[TBL] [Abstract][Full Text] [Related]
24. Sex-dependent disposition of acetaminophen sulfate and glucuronide in the in situ perfused mouse liver.
Lee JK; Abe K; Bridges AS; Patel NJ; Raub TJ; Pollack GM; Brouwer KL
Drug Metab Dispos; 2009 Sep; 37(9):1916-21. PubMed ID: 19487254
[TBL] [Abstract][Full Text] [Related]
25. Sodium valproate inhibits the movement of secretory vesicles in rat hepatocytes.
Bellringer ME; Rahman K; Coleman R
Biochem J; 1988 Jan; 249(2):513-9. PubMed ID: 3124828
[TBL] [Abstract][Full Text] [Related]
26. Disposition of amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Pharmacol; 2004 Jan; 56(1):35-41. PubMed ID: 14979999
[TBL] [Abstract][Full Text] [Related]
27. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits.
Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K
Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247
[TBL] [Abstract][Full Text] [Related]
28. Dose-dependent inhibition of transporter-mediated hepatic uptake and biliary excretion of methotrexate by cyclosporine A in an isolated perfused rat liver model.
Parasrampuria R; Mehvar R
J Pharm Sci; 2010 Dec; 99(12):5060-9. PubMed ID: 20821379
[TBL] [Abstract][Full Text] [Related]
29. Contribution of probenecid-sensitive anion transport processes at the brain capillary endothelium and choroid plexus to the efficient efflux of valproic acid from the central nervous system.
Adkison KD; Artru AA; Powers KM; Shen DD
J Pharmacol Exp Ther; 1994 Feb; 268(2):797-805. PubMed ID: 8113992
[TBL] [Abstract][Full Text] [Related]
30. Hepatobiliary disposition of liposomal amphotericin B in the isolated perfused rat liver.
Hong Y; Ramzan I; McLachlan AJ
J Pharm Sci; 2005 Jan; 94(1):169-76. PubMed ID: 15761940
[TBL] [Abstract][Full Text] [Related]
31. Hepatobiliary disposition of a drug/metabolite pair: Comprehensive pharmacokinetic modeling in sandwich-cultured rat hepatocytes.
Turncliff RZ; Hoffmaster KA; Kalvass JC; Pollack GM; Brouwer KL
J Pharmacol Exp Ther; 2006 Aug; 318(2):881-9. PubMed ID: 16690724
[TBL] [Abstract][Full Text] [Related]
32. Measurement of hepatobiliary transport.
Ballatori N
Curr Protoc Toxicol; 2004 May; Chapter 14():Unit14.5. PubMed ID: 23045099
[TBL] [Abstract][Full Text] [Related]
33. Impaired biliary elimination of beta-glucuronidase-resistant "glucuronides" of valproic acid after intravenous administration in the rat. Evidence for oxidative metabolism of the resistant isomers.
Dickinson RG; Kluck RM; Wood BT; Eadie MJ; Hooper WD
Drug Metab Dispos; 1986; 14(2):255-62. PubMed ID: 2870903
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics and pharmacodynamics of valproate analogs in rats. III. Pharmacokinetics of valproic acid, cyclohexanecarboxylic acid, and 1-methyl-1-cyclohexanecarboxylic acid in the bile-exteriorized rat.
Liu MJ; Brouwer KL; Pollack GM
Drug Metab Dispos; 1992; 20(6):810-5. PubMed ID: 1362931
[TBL] [Abstract][Full Text] [Related]
35. Disposition of beta-glucuronidase-resistant "glucuronides" of valproic acid after intrabiliary administration in the rat: intact absorption, fecal excretion and intestinal hydrolysis.
Dickinson RG; Kluck RM; Eadie MJ; Hooper WD
J Pharmacol Exp Ther; 1985 Apr; 233(1):214-21. PubMed ID: 3920383
[TBL] [Abstract][Full Text] [Related]
36. Loading-washout studies of the stereoselective sinusoidal uptake of (R)- and (s)-2-phenylpropionyl acyl glucuronide.
Shackleford DM; Evans AM; Milne RW; Nation RL
Curr Drug Metab; 2006 Oct; 7(7):817-26. PubMed ID: 17073581
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic modeling of the hepatobiliary transport mediated by cooperation of uptake and efflux transporters.
Kusuhara H; Sugiyama Y
Drug Metab Rev; 2010 Aug; 42(3):539-50. PubMed ID: 20175646
[TBL] [Abstract][Full Text] [Related]
38. Assessment of valproic acid serum-cerebrospinal fluid transport by microdialysis.
Golden PL; Brouwer KR; Pollack GM
Pharm Res; 1993 Dec; 10(12):1765-71. PubMed ID: 8302764
[TBL] [Abstract][Full Text] [Related]
39. Lorazepam-valproate interaction: studies in normal subjects and isolated perfused rat liver.
Anderson GD; Gidal BE; Kantor ED; Wilensky AJ
Epilepsia; 1994; 35(1):221-5. PubMed ID: 8112251
[TBL] [Abstract][Full Text] [Related]
40. Alteration of fexofenadine disposition in the rat isolated perfused liver following injection of bacterial lipopolysaccharide.
Tong Y; Zhang R; Ngo SN; Davey AK
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):685-9. PubMed ID: 16895540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
